Logo-aim
Arch Iran Med. 2022;25(9): 634-646. doi: 10.34172/aim.2022.99
PMID: 37543889        PMCID: PMC10685773

Study Protocol

Protocol Design for Surveillance of Risk Factors of Non–communicable Diseases During the COVID-19 Pandemic: An Experience from Iran STEPS Survey 2021

Shirin Djalalinia 1,2 ORCID, Sina Azadnajafabad 1 ORCID, Erfan Ghasemi 1 ORCID, Moein Yoosefi 1 ORCID, Negar Rezaei 1,3 ORCID, Yosef Farzi 1 ORCID, Ameneh Kazemi 1, Naser Ahmadi 1 ORCID, Maryam Nasserinejad 1,4 ORCID, Nima Fattahi 1 ORCID, Shahabeddin Rezaei 1,5, Elham Abdolhamidi 1, Elmira Foroutan Mehr 1, Rosa Haghshenas 1, Nazila Rezaei 1, Jaleh Abdi 6, Alireza Moghisi 7, Alireza Mahdavihezaveh 7, Ali Akbari Sari 6,8, Alireza Raeisi 7,9, Hamidreza Jamshidi 10, Bagher Larijani 3, Farshad Farzadfar 1,3 * ORCID

Cited by CrossRef: 5


1- Azadnajafabad S, Ahmadi N, Rezaei N, Rashidi M, Saeedi Moghaddam S, Mohammadi E, Abbasi-Kangevari M, Naderian M, Ghasemi E, Farzi Y, Kazemi A, Dilmaghani-Marand A, Yoosefi M, Rezaei S, Nasserinejad M, Fattahi N, Rezaei N, Haghshenas R, Foroutan Mehr E, Koolaji S, Razi F, Djalalinia S, Larijani B, Farzadfar F. Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021. Sci Rep. 2023;13(1) [Crossref]
2- Langroudi A, Farzi Y, Masinaei M, Varniab Z, Shahin S, Rashidi M, Moghaddam S, Rahimi S, Khalili M, Keykhaei M, Ahmadi N, Kazemi A, Ghasemi E, Azadnajafabad S, Yoosefi M, Fattahi N, Nasserinejad M, Rezaei N, Haghshenas R, Dilmaghani-Marand A, Abdolhamidi E, Djalalinia S, Rezaei N, Larijani B, Farzadfar F. Exploring metabolically healthy obesity: prevalence, characteristics, and cardiovascular risk in the Iranian population based on the STEPS 2021. J Diabetes Metab Disord. 2023; [Crossref]
3- Mehrizi R, Golestani A, Malekpour M, Karami H, Nasehi M, Effatpanah M, Rezaee M, Shahali Z, Akbari Sari A, Daroudi R, Eybpoosh S. Patterns of case fatality and hospitalization duration among nearly 1 million hospitalized COVID-19 patients covered by Iran Health Insurance Organization (IHIO) over two years of pandemic: An analysis of associated factors. PLoS ONE. 2024;19(2):e0298604 [Crossref]
4- Moradi S, Parsaei A, Saeedi Moghaddam S, Aryannejad A, Azadnajafabad S, Rezaei N, Mashinchi B, Esfahani Z, Shobeiri P, Rezaei N, Naghavi M, Larijani B, Farzadfar F. Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019. Front Public Health. 2023;11 [Crossref]
5- Ameli A, Sheikhy A, Tabatabaei-Malazy O, Ahmadi N, Ebrahimpur M, Fallahzadeh A, Rashidi M, Golestani A, Yoosefi M, Farzi Y, Dilmaghani-Marand A, Rezaei N, Larijani B, Farzadfar F. The diabetes cascade of care through the 14 years in Iran: findings of nationwide STEPS surveys 2007–2021. J Diabetes Metab Disord. 2023;22(2):1731 [Crossref]
6- Dehghanbanadaki H, Dodangeh S, Parhizkar Roudsari P, Hosseinkhani S, Khashayar P, Noorchenarboo M, Rezaei N, Dilmaghani-Marand A, Yoosefi M, Arjmand B, Khalagi K, Najjar N, Kakaei A, Bandarian F, Aghaei Meybodi H, Larijani B, Razi F. Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score. Front Cardiovasc Med. 2023;10 [Crossref]
7- Mousavi A, Sari A, Daastari F, Daroudi R. Health-related quality of life measured using the EQ-5D-3L: iranian population norms. Expert Review of Pharmacoeconomics & Outcomes Research. 2024;:1 [Crossref]
8- Khanali J, Ghasemi E, Rashidi M, Ahmadi N, Ghamari S, Azangou-Khyavy M, Malekpour M, Abbasi-Kangevari M, Hashemi S, Naderian M, Rezaei N, Dilmaghani-Marand A, Farzi Y, Kazemi A, Yoosefi M, Hajebi A, Rezaei S, Azadnajafabad S, Fattahi N, Nasserinejad M, Abdolhamidi E, Haghshenas R, Rezaei N, Djalalinia S, Larijani B, Farzadfar F. Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from STEPs survey 2021. Sci Rep. 2023;13(1) [Crossref]
9- Sasanfar B, Toorang F, Mozafari Nia M, Salehi-Abargouei A, Zendehdel K. Dietary Inflammatory Index and Breast Cancer: report from a Large-Scale Case-Control Study. Nutrition and Cancer. 2022;74(5):1692 [Crossref]
10- Nejadghaderi S, Ahmadi N, Rashidi M, Ghanbari A, Noori M, Abbasi-Kangevari M, Nasserinejad M, Rezaei N, Yoosefi M, Fattahi N, Ghasemi E, Farzi Y, Abdolhamidi E, Darman M, Djalalinia S, Farzadfar F. Physical activity pattern in Iran: Findings from STEPS 2021. Front Public Health. 2023;10 [Crossref]
11- Shahmohamadi E, Ghasemi E, Mohammadi E, Nasserinejad M, Azadnajafabad S, Malekpour M, Rashidi M, Ahmadi N, Rezaei N, Naderian M, Yoosefi M, Farzi Y, Rezaei N, Haghshenas R, Abdolhamidi E, Hajebi A, Golestani A, Kazemi A, Delaram Dizaj M, Nazari N, Momen Nia Rankohi A, Darman M, Djalalinia S, Moghisi A, Farzadfar F. “Current incidence of injuries in Iran; findings of STEPS survey 2021”. Heliyon. 2023;9(11):e20907 [Crossref]


SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.